FDA Inspection
Pacific BioLabs, Inc.Pacific BioLabs, Inc. – FDA Inspection, Jul 18, 2025
Record Details
This FDA Inspection record concerns Pacific BioLabs, Inc., with an inspection on July 18, 2025, issued by the San Francisco District Office, covering human drugs.
View Company Profile
ID · e153fb39-fdc2-4fd2-b72c-19e863a4392c
Inspection Facts
- Inspection number
- 1277213
- FDA center
- Human Drugs
Other FDA inspections of Pacific BioLabs, Inc.
11| Date | Classification | Office | Project area |
|---|---|---|---|
| September 25, 2026 | Not classified | San Francisco District Office | Drug Quality Assurance |
| June 1, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 19, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 22, 2018 | Not classified | San Francisco District Office | |
| October 27, 2017 | Not classified | San Francisco District Office |
Other documents for Pacific BioLabs, Inc.
- FDA Inspection 1337886 - 2026-09-25
- FDA Inspection 1206864 - 2023-06-01
- FDA Inspection 1046565 - 2018-03-19
- FDA Inspection 1046401 - 2018-02-22
- FDA Inspection 1040908 - 2017-10-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.